Selected article for: "acute respiratory distress and lung virus"

Author: Du, Jiang; Li, Han; Lian, Jie; Zhu, Xinxing; Qiao, Liang; Lin, Juntang
Title: Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury
  • Cord-id: tc0fylcf
  • Document date: 2020_5_24
  • ID: tc0fylcf
    Snippet: Acute lung injury (ALI), an increasingly devastating human disorder, is characterized by a multitude of lung changes arising from a wide variety of lung injuries. Viral infection is the main cause of morbidity and mortality in ALI and acute respiratory distress syndrome (ARDS) patients. In particular, influenza virus, coronavirus, and other respiratory viruses circulate in nature in various animal species and can cause severe and rapidly spread human infections. Although scientific advancements
    Document: Acute lung injury (ALI), an increasingly devastating human disorder, is characterized by a multitude of lung changes arising from a wide variety of lung injuries. Viral infection is the main cause of morbidity and mortality in ALI and acute respiratory distress syndrome (ARDS) patients. In particular, influenza virus, coronavirus, and other respiratory viruses circulate in nature in various animal species and can cause severe and rapidly spread human infections. Although scientific advancements have allowed for rapid progress to be made to understand the pathogenesis and develop therapeutics after each viral pandemic, few effective methods to treat virus-induced ALI have been described. Recently, stem cell therapy has been widely used in the treatment of various diseases, including ALI. In this review, we detail the present stem cell-based therapeutics for lung injury caused by influenza virus and the outlook for the future state of stem cell therapy to deal with emerging influenza and coronaviruses.

    Search related documents:
    Co phrase search for related documents
    • acute lung and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8
    • acute lung and low immunogenicity: 1, 2
    • acute lung and low tumorigenicity: 1
    • acute lung and lps induce: 1, 2, 3, 4, 5, 6, 7
    • acute lung and lps induce lung injury: 1
    • acute lung and luminal cell: 1, 2
    • acute lung and lung cell demise: 1
    • acute respiratory syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low immunogenicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory syndrome and low tumorigenicity: 1
    • acute respiratory syndrome and lps induce: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome and luminal cell: 1
    • acute respiratory syndrome and lung cell demise: 1